Skip to main content
DR

Dracen Pharmaceuticals

Baltimore, United States
Last funding
$2.3M
Debt FinancingAug 2023

Dracen Pharmaceuticals is a developer of novel glutamine antagonists created to deliver improved outcomes for cancer patients.

About Dracen Pharmaceuticals

How much funding has Dracen Pharmaceuticals raised?

Dracen Pharmaceuticals has raised $2.3M in total funding. The most recent round was Debt Financing. The last funding was announced in August 2023.

Who are Dracen Pharmaceuticals's investors?

Dracen Pharmaceuticals's investors include OUP (Osage University Partners), Deerfield, i&i Prague.

Where is Dracen Pharmaceuticals headquartered?

Dracen Pharmaceuticals is headquartered in Baltimore, United States.

What does Dracen Pharmaceuticals do?

Dracen Pharmaceuticals is a developer of novel glutamine antagonists created to deliver improved outcomes for cancer patients.

What stage is Dracen Pharmaceuticals at?

Dracen Pharmaceuticals is at the Debt Financing stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Dracen Pharmaceuticals — Funding & Investors." VCBacked, August 10, 2023, https://www.vcbacked.co/company/dracen-pharmaceuticals. Accessed November 17, 2026.
APA
VCBacked. (2023). Dracen Pharmaceuticals — Funding & Investors. Retrieved November 17, 2026, from https://www.vcbacked.co/company/dracen-pharmaceuticals
Wikipedia (cite web)
{{cite web |title=Dracen Pharmaceuticals — Funding & Investors |url=https://www.vcbacked.co/company/dracen-pharmaceuticals |website=VCBacked |access-date=November 17, 2026}}

Profile data sourced and verified per the VCbacked methodology · Last funding round dated

Work at Dracen Pharmaceuticals? Request a listing update

Founder contacts
m***@dracenpharma.com
linkedin.com/in/●●●●●●
Emails, phones & LinkedIn · 41,000+ verified contacts
Get instant access →